Werner Feuerer

1.1k total citations
12 papers, 837 citations indexed

About

Werner Feuerer is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Werner Feuerer has authored 12 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Hematology. Recurrent topics in Werner Feuerer's work include Blood properties and coagulation (6 papers), Acute Myocardial Infarction Research (6 papers) and Coronary Interventions and Diagnostics (3 papers). Werner Feuerer is often cited by papers focused on Blood properties and coagulation (6 papers), Acute Myocardial Infarction Research (6 papers) and Coronary Interventions and Diagnostics (3 papers). Werner Feuerer collaborates with scholars based in Germany, Netherlands and Slovakia. Werner Feuerer's co-authors include Ulrich Tebbe, Karl-Ludwig Neuhaus, W. Niederer, P. Tanswell, R. von Essen, Albrecht Vogt, K. L. Neuhaus, E. Seifried, D.C. Rijken and M Verstraete and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Werner Feuerer

12 papers receiving 764 citations

Peers

Werner Feuerer

CCM

SURGE

RNMI

HEMAT

W. Huhmann Germany

R Bernard Belgium

H. Köstering Germany

R. von Essen Germany

Ivo A. Joosen Netherlands

Mathijs O. Versteylen Netherlands

Levine Mn Canada

W. Åberg Sweden

Andrew McQuillan Australia

Selime Ayaz Türkiye

W. Huhmann Germany

Werner Feuerer

499 ×0.9

CCM

295 ×0.9

SURGE

154 ×0.6

RNMI

178 ×0.9

HEMAT

148 ×0.8

Citations per year, relative to Werner Feuerer Werner Feuerer (= 1×) peers W. Huhmann

Countries citing papers authored by Werner Feuerer

Since Specialization

Citations

This map shows the geographic impact of Werner Feuerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Feuerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Feuerer more than expected).

Fields of papers citing papers by Werner Feuerer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Feuerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Feuerer. The network helps show where Werner Feuerer may publish in the future.

Co-authorship network of co-authors of Werner Feuerer

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Feuerer. A scholar is included among the top collaborators of Werner Feuerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Feuerer. Werner Feuerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Renders, Lutz, Klemens Budde, Christian Rosenberger, et al.. (2019). First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis. PLoS ONE. 14(3). e0212023–e0212023. 51 indexed citations

Moebius, Ulrich, et al.. (2015). A Phase I Study Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of the Hepcidin Antagonist PRS-080#022. Results from a Randomized, Placebo Controlled, Double-Blind Study Following Single Administration to Healthy Subjectsa. Blood. 126(23). 536–536. 13 indexed citations

Vogt, Albrecht, R. von Essen, Ulrich Tebbe, et al.. (1994). Frequency of achieving optimal reperfusion with thrombolysis in acute myocardial infarction (analysis of four German multicenter studies). The American Journal of Cardiology. 74(1). 1–4. 12 indexed citations

Vogt, Albrecht, et al.. (1993). Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: Retrospective analysis of four german multicenter studies. Journal of the American College of Cardiology. 21(6). 1391–1395. 199 indexed citations

Tanswell, P., et al.. (1989). Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects. Clinical Pharmacology & Therapeutics. 46(2). 155–162. 64 indexed citations

Neuhaus, Karl-Ludwig, et al.. (1989). Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. Journal of the American College of Cardiology. 14(6). 1566–1569. 207 indexed citations

Tebbe, Ulrich, et al.. (1989). Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction. The American Journal of Cardiology. 64(8). 448–453. 72 indexed citations

Dierkesmann, R, et al.. (1989). [Adjuvant therapy of non-small cell bronchial cancer with mopidamol].. PubMed. 43(6). 299–304. 3 indexed citations

Neuhaus, Karl-Ludwig, Ulrich Tebbe, Martin Gottwik, et al.. (1988). Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Urokinase in Acute Myocardial Infarction: Results of the German Activator Urokinase Study (GAUS). Journal of the American College of Cardiology. 12(3). 581–587. 151 indexed citations

10.

Gottwik, Martin, Werner Feuerer, W. Niederer, et al.. (1988). [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].. PubMed. 66 Suppl 12. 102–8. 2 indexed citations

11.

Schneider, B, et al.. (1987). EFFECT OF ANTICOAGULANT TREATMENT WITH RA-233 (MOPIDAMOLE)ON SURVIVAL IN BRONCHIAL CANCER. Thrombosis and Haemostasis. 5 indexed citations

12.

Verstraete, M, et al.. (1986). Pharmacokinetics and Effects on Fibrinolytic and Coagulation Parameters of Two Doses of Recombinant Tissue-Type Plasminogen Activator in Healthy Volunteers. Thrombosis and Haemostasis. 56(1). 1–5. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact